文档介绍:Tumour Immunology:What happens when Good Cells go Bad.
Dr Alasdair Fraser
Sylvia Aitken Research Fellow Section of Experimental Haematology, Glasgow Royal Infirmary
Prevalence of cancer in UK
US Mortality, 2002
Source: US Mortality Public Use Data Tape 2002, National Center for Health Statistics, CDCP, 2004.
1. Heart Diseases 696,947
2. Cancer 557,271
3. Cerebrovascular diseases 162,672
4. Chronic lower respiratory diseases 124,816
5. Accidents (Unintentional injuries) 106,742
6. Diabetes mellitus 73,249
7. Influenza and pneumonia 65,681
8. Alzheimer disease 58,866
9. Nephritis 40,974
10. Septicemia 33,865
Rank
Cause of Death
No. deaths
% of all deaths
2005 Estimated US Cancer Cases
*Excludes basal and squamous cell skin cancers and in situ carcinomas except urinary bladder.
Source: American Cancer Society, 2005.
Men710,040
Women662,870
32% Breast
12% Lung / bronchus
11% Colon / rectum
6% Uterine corpus
4% Non-Hodgkin’s
4% Melanoma of skin
3% Ovary
3% Thyroid
2% Urinary bladder
2% Pancreas
21% All Other Sites
Prostate 33%
Lung / bronchus 13%
Colon / rectum 10%
Urinary / bladder 7%
Melanoma of skin 5%
Non-Hodgkin’s 4%
Kidney 3%
Leukemia 3%
Oral Cavity 3%
Pancreas 2%
All Other Sites 17%
2005 Estimated US Cancer Deaths
ONS=Other nervous system.
Source: American Cancer Society, 2005.
Women275,000
Men295,280
27% Lung and bronchus
15% Breast
10% Colon and rectum
6% Ovary
6% Pancreas
4% Leukemia
3% Non-Hodgkin’s
3% Uterine corpus
2% Multiple myeloma
2% Brain / ONS
22% All other sites
Lung / bronchus 31%
Prostate 10%
Colon / rectum 10%
Pancreas 5%
Leukemias 4%
Esophagus 4%
Liver / bile duct 3%
Non-Hodgkin’s 3%
Urinary / bladder 3%
Kidney 3%
All other sites 24%
Relative Survival (%) during Three Time Periods
*5-year relative survival rates based on follow up of patients through 2001.
Source: SEER Program (1975-2001), NCI 2004.
Site
1974-1976
1983-1985
1995-2000